Spectrum of emergency department presentation in patients of acute intermittent porphyria: Experience from a North Indian tertiary care center

Neurology India

Volumn 58, Issue 1, 2010, Pages 95-98

  Kumar, Susheel ^a   Sharma, Navneet ^a   Modi, Manish ^a   Sharma, Aman ^a   Mahi, Sushil ^a   Varma, Subhash ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute intermittent porphyria; Emergency presentation; Hyponatremia

Indexed keywords

DIAZEPAM; DICLOFENAC; ISONIAZID; METOCLOPRAMIDE; PANTOPRAZOLE; PENTAZOCINE; PHENOBARBITAL; PHENYTOIN; POTASSIUM; RABEPRAZOLE; RIFAMPICIN; SODIUM; TRAMADOL;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ADRENERGIC ACTIVITY; ADULT; ARTICLE; CENTRAL PONTINE MYELINOLYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG INDUCED DISEASE; ECHOGRAPHY; EMERGENCY WARD; FEMALE; HUMAN; HYPONATREMIA; INDIA; MALE; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROLOGIC DISEASE; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; SEIZURE; SODIUM BLOOD LEVEL; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; ADULT; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; HYPONATREMIA; INDIA; MALE; PORPHYRIA, ACUTE INTERMITTENT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77949579006     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.60410     Document Type: Article

References (17)

1. Desnick RJ. The Porphyrias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 16th ed. McGraw-Hill Press; 2005. p. 2303-2308
2. Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, et al. Recommendations for the diagnosis and treatment of the acute porphyries. Ann Intern Med 2005;142:439-450
3. Elder GH, Hift RJ, Meissner PN. The acute porphyrias. Lancet 1997;349:1613-1617
4. Kauppinen R. Porpyrias. Lancet 2005;365:241-252
5. Hift RJ. Meissner PN. An analysis of 112 acute porphyric attacks in Cape-Town, South Africa. Medicine 2005;84:48-60.
6. Liu YP, Lien WC, Fang CC, Lai TI, Chen WJ, Wang HP. ED presentation of acute porphyria. Am J Emerg Med 2005;23:164-167
7. Andersson C, Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med 1994;236:169-175
8. Gupta GL, Saksena HC, Gupta BD. Autonomic neuropathy and hypertension in acute intermittent porphyria. J Assoc Physicians India 1983;31:259.
9. Bravenboer B, Erkelens DW. Acute hypertension mimicking Pheochromocytoma as main presenting feature of acute intermittent porphyria. Lancet 1989;2:928.
10. Singh V, Sud K, Kohli HS, Gupta KL, Sakhuja V. Acute intermittent porphyria: An unusual cause of malignant hypertension. J Assoc Physicians India 2003;51:225-226
11. Bonkowsky HL, Schady W. Neurologic manifestations of acute intermittent porphyria. Semin Liver Dis 1982;2:108-124
12. Bylesio I, Forsgren L, Lithner F, Boman K. Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia 1996;37:230-235
13. Zarda M, Grandi R, Erli LC, Mirabile D, Brambilla A. Treatment of seizures in acute intermittent porphyria: Safety and efficacy of gabapentin. Seizure 1998;7:415-416
14. Zaaterh MM. Levitiracetam in porphyric status epilepticus: A case report. Clin Neuropharmacol 2005;5:243-244
15. Bilo L, Meo R, Fulvia de leva M. Levetiracetam in idiopathic generalized epilepsy and porphyria cutanea tarda. Clin Drug Investig 2006;26:357-359
16. Hahan M, Gildemeister OS, Krauss GL, Pepe JA, Lambrecht RW, Donohue S, et al. Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: Potential implications for patients with acute porphyria. Neurology 1997;49:97-106.
17. Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: Risks of valproate and clonazepam. Neurology 1980;30:588-592